drugset / Trial / NCT00137761
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
Phase 2
Completed
32 enrolled
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center · collabBrigham and Women's Hospital · collabMassachusetts General Hospital · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out what activity the combination of docetaxel and Iressa have against metastatic pancreatic cancer.
Timeline
- Start
- 2004-10
- Primary completion
- 2007-06
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Gefitinib | Small molecule | — | Oral |